Statistics for Therapeutic targeting of immunometabolism reveals a critical reliance on hexokinase 2 dosage for microglial activation and Alzheimer’s progression
Total visits
| views | |
|---|---|
| Therapeutic targeting of immunometabolism reveals a critical reliance on hexokinase 2 dosage for microglial activation and Alzheimer’s progression | 1 |
Total visits per month
| views | |
|---|---|
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 1 |
| June 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:9aa917b2-93f5-4f3e-82c4-6122c00b811e | 9 |
| java.util.UUID:b572e8dc-40e3-4e00-a883-879c0eedf81e | 4 |
| java.util.UUID:6944e53c-5c24-47ed-b284-9f5f513f30f6 | 2 |
| Codocedo2024Therapeutic-AAM.pdf | 1 |
Top country views
| views | |
|---|---|
| United States | 1 |